Synergistic anti-inflammatory effect of gut microbiota and lithocholic acid on liver fibrosis

Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, et al. A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell. 2013;153:601–13.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Fabre T, Molina MF, Soucy G, Goulet JP, Willems B, Villeneuve JP, et al. Type 3 cytokines IL-17A and IL-22 drive TGF-beta-dependent liver fibrosis. Sci immunol. 2018;3(28):7754.

Article  Google Scholar 

Mountford S, Effenberger M, Noll-Puchta H, Griessmair L, Ringleb A, Haas S, et al. Modulation of liver inflammation and fibrosis by interleukin-37. Front Immunol. 2021;12: 603649.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Bataller R, Brenner DA. Liver fibrosis. J Clin Investig. 2005;115:209–18.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Peng H, Sun R. Liver-resident NK cells and their potential functions. Cell Mol Immunol. 2017;14(11):890–294.

CAS  PubMed Central  Article  Google Scholar 

Li M, Li C, Wu X, Chen T, Ren L, Xu B, et al. Microbiota-driven interleukin-17 production provides immune protection against invasive candidiasis. Crit Care. 2020;24:268.

PubMed  PubMed Central  Article  Google Scholar 

Park JW, Jung KH, Lee JH, Moon SH, Cho YS, Lee KH. (89)Zr anti-CD44 immuno-PET monitors CD44 expression on splenic myeloid cells and HT29 colon cancer cells. Sci Rep. 2021;11:3876.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Campana L, Iredale JP. Regression of liver fibrosis. Semin Liver Dis. 2017;37:1–10.

PubMed  Article  Google Scholar 

Dong F, Jiang S, Li J, Wang Y, Zhu L, Huang Y, et al. The histone demethylase KDM4D promotes hepatic fibrogenesis by modulating Toll-like receptor 4 signaling pathway. EBioMedicine. 2019;39:472–83.

PubMed  Article  Google Scholar 

Wammers M, Schupp AK, Bode JG, Ehlting C, Wolf S, Deenen R, et al. Reprogramming of pro-inflammatory human macrophages to an anti-inflammatory phenotype by bile acids. Sci Rep. 2018;8:255.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8:958–69.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Bernstein H, Bernstein C, Payne CM, Dvorak K. Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gastroenterol. 2009;15:3329–40.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Zheng Y, Yue C, Zhang H, Chen H, Liu Y, Li J. Deoxycholic acid and lithocholic acid alleviate liver injury and inflammation in mice with klebsiella pneumoniae-induced liver abscess and bacteremia. J Inflamm Res. 2021;14:777–89.

PubMed  PubMed Central  Article  Google Scholar 

Sinha SR, Haileselassie Y, Nguyen LP, Tropini C, Wang M, Becker LS, et al. Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation. Cell Host Microbe. 2020;27(659–670): e5.

Google Scholar 

Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science. 2013;342:967–70.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Ye JZ, Lv LX, Wu WR, Li YT, Shi D, Fang DQ, et al. Butyrate protects mice against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis by improving gut barrier function, attenuating inflammation and reducing endotoxin levels. Front Microbiol. 2018. https://doi.org/10.3389/fmicb.2018.01967.

Article  PubMed  PubMed Central  Google Scholar 

Huang C, Shao J, Lou C, Wu F, Ge T, Gao H, et al. Reduced energy metabolism impairs t cell-dependent b cell responses in patients with advanced HBV-related cirrhosis. Front Immunol. 2021;12: 660312.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003;425:577–84.

CAS  PubMed  Article  Google Scholar 

Oakley F, Meso M, Iredale JP, Green K, Marek CJ, Zhou X, et al. Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. Gastroenterology. 2005;128:108–20.

CAS  PubMed  Article  Google Scholar 

Han QJ, Mu YL, Zhao HJ, Zhao RR, Guo QJ, Su YH, et al. Fasudil prevents liver fibrosis via activating natural killer cells and suppressing hepatic stellate cells. World J Gastroenterol. 2021;27:3581–94.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride. Hepatology; 49.

Ajuebor MN, Aspinall AI, Zhou F, Le T, Yang Y, Urbanski SJ, et al. Lack of chemokine receptor ccr5 promotes murine fulminant liver failure by preventing the apoptosis of activated cd1d-restricted nkt cells. J Immunol. 2005;174:8027–37.

CAS  PubMed  Article  Google Scholar 

Mehla K, Singh PK. Metabolic regulation of macrophage polarization in cancer. Trends cancer. 2019;5:822–34.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Mehla K, Singh PK. Metabolic regulation of macrophage polarization in cancer. Trends in cancer. 2019;5(12):822–34.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Chan YT, Wang N, Tan HY, Li S, Feng Y. Targeting hepatic stellate cells for the treatment of liver fibrosis by natural products: is it the dawning of a new era? Front Pharmacol. 2020;11:548.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin invest. 1998;102:538–49.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Singh HD, Otano I, Rombouts K, Singh KP, Peppa D, Gill US, et al. TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis. Sci Rep. 2017;7:5514.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Shin NR, Whon TW, Bae JW. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 2015;33:496–503.

CAS  PubMed  Article  Google Scholar 

Caporaso JG, Lauber CL, Costello E. Moving pictures of the human microbiome. Genome Biol. 2011;12:R50.

PubMed  PubMed Central  Article  Google Scholar 

Lavelle A, Lennon G, O"Sullivan O, Docherty N, Balfe A, Maguire A, et al. 2015 Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers. Gut:gutjnl-2014–307873.

Cheema SK, Cikaluk D, Agellon LB. Dietary fats modulate the regulatory potential of dietary cholesterol on cholesterol 7 alpha-hydroxylase gene expression. J Lipid Res. 1997;38:315–23.

CAS  PubMed  Article  Google Scholar 

Aydin MM, Akcali KC. Liver fibrosis. Turkish J gastroenterology. 2018;29:14–21.

Article  Google Scholar 

Zhou Y, Zhang Q, Kong Y, Guo X, Zhang H, Fan H, et al. Insulin-like growth factor binding protein-related protein 1 activates primary hepatic stellate cells via autophagy regulated by the pi3k/akt/mtor signaling pathway. Dig Dis Sci. 2020;65:509–23.

CAS  PubMed  Article  Google Scholar 

Glassner A, Eisenhardt M, Kokordelis P, Kramer B, Wolter F, Nischalke HD, et al. Impaired CD4(+) T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients. J Hepatol. 2013;59:427–33.

CAS  PubMed  Article  Google Scholar 

Han QJ, Mu YL, Zhao HJ, Zhao RR, Zhang J. Fasudil prevents liver fibrosis via activating natural killer cells and suppressing hepatic stellate cells. World J Gastroenterol. 2021;27:3581–94.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Liu L, Jin M, Tao Q, Yu L, Du J, Wang C, et al. Effective amelioration of liver fibrosis through lentiviral vector carrying toxoplasma gondii gra15ii in murine model. Front Immunol. 2018;9:1572.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Wang Y, Tang B, Long L, Luo P, Xiang W, Li X, et al. Improvement of obesity-associated disorders by a small-molecule drug targeting mitochondria of adipose tissue macrophages. Nat Commun. 2021;12:102.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K. Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov. 2008;7:678–93.

CAS  PubMed  Article  Google Scholar 

Wei M, Huang F, Zhao L, Zhang Y, Yang W, Wang S, et al. A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility. EBioMedicine. 2020;55: 102766.

留言 (0)

沒有登入
gif